FZMD (Fuse Medical) ROCE %: 20.50% (As of Jun. 2023)

What is Fuse Medical ROCE %?

Fuse Medical FZMD 12 ROCE % is 20.50% as of Jun. 2023. GuruFocus rates FZMD with a GF Score™ of 12/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fuse Medical's annualized ROCE % for the quarter that ended in Jun. 2023 was 20.50%.

Fuse Medical (OTCPK:FZMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fuse Medical ROCE % Related Terms

Fuse Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Fuse Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuse Medical ROCE % Chart

Fuse Medical Annual Data

Trend

Aug13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

28.16

-18.95

-12.81

-16.10

41.85

Fuse Medical Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial															-14.28	2.33	191.83	-9.15	20.50

12GF Score

Fuse Medical Inc FZMD

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fuse Medical ROCE % Calculation

Fuse Medical's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	3.293	/	( ( (18.304 - 9.942)	+	(19.763 - 12.388) )	/ 2 )
	=	3.293	/	( (8.362	+	7.375)	/ 2 )
	=	3.293	/	7.8685
	=	41.85 %

Fuse Medical's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	1.476	/	( ( (18.433 - 11.287)	+	(19.318 - 12.064) )	/ 2 )
	=	1.476	/	( ( 7.146	+	7.254 )	/ 2 )
	=	1.476	/	7.2
	=	20.50 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 20.50% mean?

Fuse Medical (FZMD) has a ROCE % of 20.50% as of Jun. 2023.

Is Fuse Medical's ROCE % too high?

Fuse Medical's current ROCE % is 20.50%. The Medical Devices & Instruments industry median ROCE % is 2.23. Fuse Medical's value of 20.50% is 819.3% above this industry median. Overall, Fuse Medical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Fuse Medical's ROCE % compare to GTHP and SONX?

Fuse Medical's ROCE % of 20.50% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Fuse Medical's value of 20.50% is 819.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuse Medical's current ROCE % of 20.50% is 819.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuse Medical's current ROCE % is 20.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fuse Medical stock overvalued right now?

Fuse Medical (FZMD) has a current ROCE % of 20.50%. The current ROCE % is 20.50% and 819.3% above the Medical Devices & Instruments industry median of 2.23. Fuse Medical's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Fuse Medical (FZMD), the current ROCE % is 20.50% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fuse Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies GTHP SONX PBIO TBIO BIOL AIMD QLIS VVOS VAPO CMXC ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH

Address 4343 Sigma Road, Suite 500, Farmers Branch, TX, USA, 75244

Website https://www.fusemedical.com

Fuse Medical Inc is a manufacturer, distributor, and wholesaler of medical device implants, offering portfolio of orthopedic implants and biologics including: internal fixation products, upper and lower extremity plating and total joint reconstruction implants, soft tissue fixation and augmentation for sports medicine procedures, spinal implants for trauma, degenerative disc disease and deformity indications, and osteo-biologics, regenerative and connective tissues, which include human allografts, substitute bone materials, tendons, and regenerative tissues. Its portfolio of Orthopedic Implants and Biologics provide products to assist surgeons with positive patient outcomes and cost-effective solutions for its customers including hospitals, medical facilities, and sub-distributors.

12GF Score

Get the complete analysis for FZMD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02

Price

View FZMD Analysis

See ROCE % data for all stocks →